Isochlorogenic acid BCAS# 14534-61-3 |
- Isochlorogenic acid C
Catalog No.:BCN2498
CAS No.:57378-72-0
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 14534-61-3 | SDF | Download SDF |
| PubChem ID | 5281780 | Appearance | White-pale yellow powder |
| Formula | C25H24O12 | M.Wt | 516.45 |
| Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
| Synonyms | 3,4-Dicaffeoylquinic Acid; Isochlorogenic Acid B; 3,4-Di-O-Caffeoylquinic Acid | ||
| Solubility | DMSO : 50 mg/mL (96.81 mM; Need ultrasonic) | ||
| Chemical Name | (1S,3R,4R,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxycyclohexane-1-carboxylic acid | ||
| SMILES | C1C(C(C(CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O | ||
| Standard InChIKey | UFCLZKMFXSILNL-PSEXTPKNSA-N | ||
| Standard InChI | InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(35,24(33)34)11-19(30)23(20)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23-,25+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Isochlorogenic acid B has antioxidant activity, it is a potential PDE-5 inhibitor. |
| Targets | PDE-5 |
| Kinase Assay | Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database.[Pubmed: 20085380]J Biomol Struct Dyn. 2010 Apr;27(5):627-40.From docking analyses, Isochlorogenic acid B was identified as the most potential inhibitory compound. De novo evolution designed 47 derivatives. Of the 47 derivatives, seven were able to map into the pharmacophore model, and these seven compounds were suggested to be the most promising leads for inhibiting PDE-5. An analysis of the hydrogen bond interactions formed between the docked ligands and PDE-5 identified ASN662, SER663 and GLN817 as the most frequently interacting residues. A total of eight novel leading compounds were identified to have favorable interaction with PDE-5. These compounds all had hydrogen bond interactions with three key residues that could be further investigated for understanding of PDE-5 and ligands interaction. |
| Structure Identification | PLoS One. 2014 Sep 2;9(9):e106254.The activity-integrated method for quality assessment of reduning injection by on-line DPPH-CE-DAD.[Pubmed: 25181475]A sensitive on-line DPPH-CE-DAD method was developed and validated for both screening and determining the concentration of seven antioxidants of Reduning injection. The pH and concentrations of buffer solution, SDS, β-CD and organic modifier were studied for the detection of DPPH and seven antioxidants. By on-line mixing DPPH and sample solution, a DPPH-CE method for testing the antioxidant activity of the complex matrix was successfully established and used to screen the antioxidant components of Reduning injection. Then, antioxidant components including caffeic acid, isochlorogenic acid A, Isochlorogenic acid B, isochlorogenic acid C, chlorogenic acid, neochlorogenic acid and cryptochlorogenic acid were quantified by the newly established CE-DAD method. |
Isochlorogenic acid B Dilution Calculator
Isochlorogenic acid B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9363 mL | 9.6815 mL | 19.363 mL | 38.7259 mL | 48.4074 mL |
| 5 mM | 0.3873 mL | 1.9363 mL | 3.8726 mL | 7.7452 mL | 9.6815 mL |
| 10 mM | 0.1936 mL | 0.9681 mL | 1.9363 mL | 3.8726 mL | 4.8407 mL |
| 50 mM | 0.0387 mL | 0.1936 mL | 0.3873 mL | 0.7745 mL | 0.9681 mL |
| 100 mM | 0.0194 mL | 0.0968 mL | 0.1936 mL | 0.3873 mL | 0.4841 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
3,4-Dicaffeoylquinic acid is a reference substance of a common phytochemical found in Echinacea (Echinacea sp.); dietary supplement, herb, or plant testing applications with this reference material include material characterization, adulterant identification, or method validation.
References:
[1]. Takemura T, et al. 3,4-Dicaffeoylquinic Acid, a Major Constituent of Brazilian Propolis, Increases TRAIL Expression and Extends the Lifetimes of Mice Infected with the Influenza A Virus. Evid Based Complement Alternat Med. 2012;2012:946867.
- Dihydropinosylvin
Catalog No.:BCN6258
CAS No.:14531-52-3
- Bergenin pentaacetate
Catalog No.:BCN6257
CAS No.:14531-47-6
- TC-E 5002
Catalog No.:BCC5608
CAS No.:1453071-47-0
- A 77636 hydrochloride
Catalog No.:BCC7159
CAS No.:145307-34-2
- 20(R)-Protopanaxatriol
Catalog No.:BCN1079
CAS No.:1453-93-6
- Diarylcomosol III
Catalog No.:BCN7201
CAS No.:1452487-93-2
- Sahandol
Catalog No.:BCN6996
CAS No.:1452398-07-0
- Delgrandine
Catalog No.:BCN8122
CAS No.:145237-05-4
- Clobenpropit dihydrobromide
Catalog No.:BCC6781
CAS No.:145231-35-2
- CALP1
Catalog No.:BCC5873
CAS No.:145224-99-3
- Punctanecine
Catalog No.:BCN2018
CAS No.:145204-91-7
- Rizatriptan Benzoate
Catalog No.:BCC3852
CAS No.:145202-66-0
- Sideroxylonal A
Catalog No.:BCN1645
CAS No.:145382-68-9
- GDC-0994
Catalog No.:BCC6371
CAS No.:1453848-26-4
- 1,4,7-Eudesmanetriol
Catalog No.:BCN1646
CAS No.:145400-02-8
- Homalomenol A
Catalog No.:BCN1647
CAS No.:145400-03-9
- L-692,585
Catalog No.:BCC7305
CAS No.:145455-35-2
- Heterophyllin B
Catalog No.:BCN2768
CAS No.:145459-19-4
- Isolintetralin
Catalog No.:BCN3052
CAS No.:145459-30-9
- PU-WS13
Catalog No.:BCC6425
CAS No.:1454619-14-7
- Furano(2'',3'',7,6)-4'-hydroxyflavanone
Catalog No.:BCN6405
CAS No.:1454619-70-5
- LY3009120
Catalog No.:BCC3985
CAS No.:1454682-72-4
- 4-Benzoylpyridine
Catalog No.:BCC8697
CAS No.:14548-46-0
- PF-06463922
Catalog No.:BCC5568
CAS No.:1454846-35-5
Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database.[Pubmed:20085380]
J Biomol Struct Dyn. 2010 Apr;27(5):627-40.
Erectile dysfunction (ED) is a sexual disorder mainly caused by decrease in cellular concentration of cyclic guanosine monophosphate (cGMP), which is degraded by phosphodiesterase type-5 (PDE-5). As a potent therapeutic target, inhibitors such as Viagra , Cialis, and Levitra have already been developed to target PDE-5 for treating ED; traditional Chinese medicine, Epimedium sagittatum, also has shown prominent results as well. To developed new PDE-5 inhibitors, we performed a virtual screening of traditional Chinese medicine (TCM) database and docking analyses to identify candidates. Known PDE-5 inhibitors were used to construct a three dimensional quantitative structure-activity relationship (3D QSAR) model by HypoGen program. From docking analyses, Isochlorogenic acid B was identified as the most potential inhibitory compound. De novo evolution designed 47 derivatives. Of the 47 derivatives, seven were able to map into the pharmacophore model, and these seven compounds were suggested to be the most promising leads for inhibiting PDE-5. An analysis of the hydrogen bond interactions formed between the docked ligands and PDE-5 identified ASN662, SER663 and GLN817 as the most frequently interacting residues. A total of eight novel leading compounds were identified to have favorable interaction with PDE-5. These compounds all had hydrogen bond interactions with three key residues that could be further investigated for understanding of PDE-5 and ligands interaction.
The activity-integrated method for quality assessment of reduning injection by on-line DPPH-CE-DAD.[Pubmed:25181475]
PLoS One. 2014 Sep 2;9(9):e106254.
A sensitive on-line DPPH-CE-DAD method was developed and validated for both screening and determining the concentration of seven antioxidants of Reduning injection. The pH and concentrations of buffer solution, SDS, beta-CD and organic modifier were studied for the detection of DPPH and seven antioxidants. By on-line mixing DPPH and sample solution, a DPPH-CE method for testing the antioxidant activity of the complex matrix was successfully established and used to screen the antioxidant components of Reduning injection. Then, antioxidant components including caffeic acid, isochlorogenic acid A, Isochlorogenic acid B, isochlorogenic acid C, chlorogenic acid, neochlorogenic acid and cryptochlorogenic acid were quantified by the newly established CE-DAD method. Finally, the total antioxidant activity and the multiple active components were selected as markers to evaluate the quality of Reduning injection. The results demonstrated that the on-line DPPH-CE-DAD method was reagent-saving, rapid and feasible for on-line simultaneous determination of total pharmacological activity and contents of multi-components samples. It was also a powerful method for evaluating the quality control and mechanism of action of TCM injection.
